Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-12-11Clinical Trial Update: Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol Addiction [NA]
A clinical trial update on the effectiveness of a hospital addiction service for treating opioid use disorder and alcohol use disorder; curr…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Malmö Treatment Referral and Intervention Study [NA]
A completed clinical trial in Malmö evaluating treatment referral and intervention for heroin addiction and substance use disorders.
-
FDA approval · 2014-11-05FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride submitted by SpecGx LLC, granting supplemental approval for a generic pr…
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE) [NA]
This document reports the completion of the MATICCE trial evaluating medication-assisted treatment implementation in community correctional …
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT [Phase 4]
Phase 4 study investigating the mechanism of action of depot naltrexone in heroin-dependent patients using functional MRI and SPECT imaging.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate Addiction [Phase 3]
The NAOMI Phase 3 trial comparing medically prescribed diacetylmorphine with oral methadone for chronic opioid dependence has completed.
-
FDA approval · 2014-09-22FDA Approved: METHADOSE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Methadose (methadone hydrochloride) submitted by SpecGx LLC.
-
FDA approval · 2014-08-29FDA Approved: VIVITROL — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for VIVITROL (naltrexone) submitted by Alkermes, potentially expanding its labeling or indicatio…
-
FDA approval · 2014-08-19FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
The FDA approved a supplemental application from VistaPharm, LLC for methadone hydrochloride, updating an existing ANDA product.
-
FDA approval · 2014-08-19FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc. under an ANDA.
-
FDA approval · 2014-08-19FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., authorizing the generic product…
-
FDA approval · 2014-08-19FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Methadone Hydrochloride from Ascend Laboratories, LLC, confirming approval of a generic methadon…
-
FDA approval · 2014-08-19FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
The FDA approved a supplemental application for methadone hydrochloride by VistaPharm, LLC under ANDA090707, enabling a generic methadone hy…
-
FDA approval · 2014-08-19FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for methadone hydrochloride from SpecGx LLC for this generic product.
-
FDA approval · 2014-08-12FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
The FDA approved a supplemental application for SUBOXONE, the buprenorphine/naloxone product from Indivior, indicating regulatory approval f…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy [Phase 1]
Phase 1 study completed evaluating Mindfulness-Oriented Recovery Enhancement (MORE) for adults with chronic pain receiving opioid therapy.
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: DBT Compared to I/GDC for the Treatment of Opiate Addiction in Emotionally Dysregulated Patients. - 1 [NA]
A completed clinical trial comparing Dialectical Behavior Therapy (DBT) to Individual and Group Drug Counseling (I/GDC) for opioid use disor…
-
FDA approval · 2014-07-23FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride submitted by SpecGx LLC (ANDA 040517). The action represents approval of…
-
FDA approval · 2014-07-23FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental ANDA for Ascend Laboratories' methadone hydrochloride, a generic opioid product.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: An Adherence Tool to Manage Narcotic -Addicted HIV Patients [NA]
Clinical trial update indicating completion of a study evaluating an adherence tool for HIV patients with opioid addiction.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Memantine as a Supplement to Naltrexone in Treating Heroin Dependence [Phase 2, Phase 3]
Memantine was studied as a supplement to naltrexone for heroin/opioid dependence. The trial completed Phase 2 and Phase 3 with results poste…
-
FDA approval · 2014-06-27FDA Approved: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a generic combination product of buprenorphine hydrochloride and naloxone hydrochloride dihydrate from Hikma for opioid use dis…
-
CLINICAL_TRIALS withdrawal · 2014-06-10Clinical Trial Update: Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents [Phase 4]
A Phase 4 clinical trial comparing buprenorphine/naloxone with naltrexone in opioid-dependent adolescents has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1 [NA]
A completed trial analyzes the effectiveness of opiate replacement therapy administered before release from a correctional facility. Results…
-
FDA approval · 2014-06-05FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
The FDA approved a supplemental application for Suboxone (buprenorphine/naloxone) from Indivior, related to its use for opioid use disorder.